GENMAB A/S Research And Development Expense

Quick Answer

GENMAB A/S reported Research And Development Expense of $1.61 billion for the year ending 2025.

  • GENMAB A/S showed an increase of +13.6% in Research And Development Expense from 2024 to 2025.
  • This data is from GENMAB A/S's annual report (Form 10-K), filed with the SEC on February 17, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2017 to 2025), GENMAB A/S's Research And Development Expense has grown by 83.8%.
  • Historical annual values: Fiscal year 2025: $1.61 billion | Fiscal year 2024: $1.41 billion | Fiscal year 2023: $1.11 billion | Fiscal year 2019: $2.39 billion | Fiscal year 2018: $1.43 billion | Fiscal year 2017: $874.00 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: